China's AI Healthcare Ambitions Hit Practical Barriers

China's state-backed initiative to integrate artificial intelligence into healthcare, part of its broader 'AI+ plan,' has made progress but now faces non-technical challenges. Practitioners highlight issues such as data interoperability, institutional incentives, and unclear payment models as key obstacles. The article suggests that these systemic problems require policy changes rather than just technological innovation.

China's State Council launched its nationwide AI+ initiative in 2025, designating health as a priority application area. Since then, leading hospitals have amassed substantial health-data assets, and medical-focused large language models have advanced rapidly, with consumer health apps reaching the market. However, commercial success remains elusive—few AI health products have secured approval and reimbursement through public medical insurance, limiting their domestic market viability.

The country's data governance framework is also in flux. After creating the National Data Administration in 2023 to build a national data market, policy language has shifted from "digitalization" toward "digital intelligence," emphasizing that data's value materializes only through enabling measurable outcomes. Practitioners at recent Beijing and Shanghai forums consistently identified the same bottlenecks: insufficient high-quality datasets, limited institutional data-sharing, and unresolved questions about whether AI genuinely reduces healthcare costs.